About LifeMap Sciences
LifeMap Sciences is a subsidiary of BioTime, Inc. Operations worldwide are carried out from its offices in California, Massachusetts, Tel Aviv and Hong Kong.
LifeMap Sciences' core technology and business is based on its integrated database suite, the discovery platform for biomedical and stem-cell research. This platform includes GeneCards®: the leading human gene database; LifeMap Discovery™, the database of embryonic development, stem cell research and regenerative medicine; and MalaCards, the human disease database. LifeMap Sciences also markets PanDaTox, a recently developed, searchable database that can aid in the discovery of new antibiotics and biotechnologically beneficial products.
LifeMap Sciences also markets research reagent products manufactured by BioTime, including PureStem™ human progenitor cell lines, GMP human embryonic stem (hES) cell lines,
growth media and differentiation kits for progenitor cell lines.
For more detail see bioreagents.lifemapsc.com
LifeMap Sciences is also engaged in therapeutics discovery aimed toward generation of stem cell based regenerative medicine products and other healthcare products based on stem cells, including on PureStem™ human progenitor cell lines.
We are pleased to announce the public release of LifeMap Discovery™ version 1.1, which includes significant enhancements of content
related to disease targets for stem cell therapy, cells involved in various diseases (such as Parkinson’s disease and age related macular degeneration),
and a large number of newly added genes relevant to developmental and stem cell biology.
May 07, 2013
BioTime and Subsidiary LifeMap Sciences Announce Release of Enhanced LifeMap BioReagents™ Portal Offering Additional PureStem™ Human Progenitor Cells Including Those for Diabetes Research
ALAMEDA, Calif.--(BUSINESS WIRE)--May. 7, 2013-- BioTime, Inc. (NYSE MKT: BTX) and subsidiary, LifeMap Sciences, today announced the release of the enhanced LifeMap BioReagents™ portal (http://bioreagents.lifemapsc.com/) featuring an improved user interface, product descriptions, and customer support options, as well as the addition of new PureStem™ progenitor cells to the site